• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee

Research review

Does turmeric help with nerve pain (neuropathy)? What the research does and doesn't show

The most direct human evidence available — a 16-week randomized trial in 97 people with diabetic nerve pain — found nanocurcumin did not improve pain, nerve function or metabolic markers compared with placebo. Animal studies have shown a protective effect on nerve tissue, but that hasn't translated into a human result.

By Electric Tiger Editorial

The evidence doesn't support turmeric or curcumin as a treatment for neuropathy. The one randomized controlled trial designed specifically to test this in humans — 97 people with diabetic nerve pain, treated for 16 weeks — found nanocurcumin performed no better than placebo on pain, nerve function or disability scores. Animal studies have found a protective effect on nerve tissue; that hasn't been confirmed in the human trial that tested it directly.

What the evidence doesn't support

It doesn't support turmeric, curcumin or nanocurcumin as a treatment for neuropathy, nerve pain or nerve damage of any kind, including diabetic peripheral neuropathy. It doesn't support using animal research as a stand-in for a human result, since the one human trial that tested curcumin's effect on nerve pain directly found none. And it doesn't support treating a positive result on mood (depression or anxiety scores) in people with neuropathy as evidence that curcumin affects the neuropathy itself — those are different measurements.

What the trials found

The most direct evidence is also the most recent and best-designed: a 2025 randomized, double-blind, placebo-controlled trial conducted at a diabetes clinic in Tehran, enrolling 97 adults with type 2 diabetes and diagnosed diabetic peripheral neuropathy. Participants took 80 mg/day of nanocurcumin (40 mg twice daily) or a matched placebo for 16 weeks. The trial's own primary goal was pain reduction, measured on a numerical rating scale, with nerve function and disability scores as secondary measures. There was no significant difference between the nanocurcumin and placebo groups on pain, nerve function, or disability scores after 16 weeks, and no improvement in metabolic or cardiovascular markers either. The supplement was well tolerated, with no major adverse events — this was a negative result on effectiveness, not a safety concern. The study authors note this is the type of trial the field had been missing: prior support for curcumin and neuropathy came almost entirely from animal research, and this was only the second randomized trial in humans to test it, and the first that specifically measured pain and nerve-function outcomes with a null result reported.

The animal research the human trial was meant to follow up on is real, and worth describing honestly rather than dismissing. In diabetic rats, curcumin given for 4 weeks at 100–150 mg/kg/day improved nerve conduction velocity and reduced nerve-cell death in the sciatic nerve compared with untreated diabetic rats, without changing blood sugar itself. That's a plausible biological mechanism in an animal model — it just hasn't translated into the human trial result described above.

A separate, smaller human trial adds a different data point that's easy to conflate with a neuropathy result but isn't one: an 8-week trial of 80 mg/day nano-curcumin in 80 people with diabetes and diagnosed peripheral neuropathy found a significant improvement in depression and anxiety scores versus placebo. That trial measured mood, using a standard psychological questionnaire — it didn't measure nerve pain, nerve conduction, or any physical neuropathy outcome, so it isn't evidence that curcumin improved the neuropathy itself.

Study Population Dose What it measured Result
2025 RCT 97 adults, diabetic peripheral neuropathy 80 mg/day nanocurcumin, 16 weeks Pain, nerve function, disability No significant difference vs placebo
Animal study Diabetic rats 100-150 mg/kg/day, 4 weeks Nerve conduction, nerve-cell death Improved vs untreated diabetic rats
2020 RCT 80 adults, diabetic neuropathy 80 mg/day nano-curcumin, 8 weeks Depression and anxiety scores Improved vs placebo (mood, not nerve outcomes)

Questions people ask

Does turmeric help neuropathy?

The most direct human evidence says no. A 16-week randomized trial of 97 people with diabetic peripheral neuropathy found nanocurcumin performed no better than placebo on pain, nerve function or disability scores.

Is turmeric good for nerve pain?

The one trial that tested this directly in humans found no benefit for pain compared with placebo. Animal studies have shown a protective effect on nerve tissue, but that hasn't been confirmed in people.

How much turmeric should I take for neuropathy?

There isn't a dose to recommend, because the trial that tested curcumin for this specific purpose found no benefit at the dose it used (80 mg/day nanocurcumin, 16 weeks). A higher or different dose hasn't been shown to work either — it simply hasn't been tested.

Can turmeric help with diabetic nerve damage?

Animal research suggested it might, by protecting nerve tissue in diabetic rats. The one human trial designed to test that directly, in people with diagnosed diabetic peripheral neuropathy, found no significant improvement over placebo.

When to talk to a doctor

Nerve pain, numbness or tingling — especially in the hands or feet, and especially with diabetes — is worth evaluating with a doctor rather than addressing with a supplement alone. Turmeric and curcumin are not a treatment for neuropathy, and the most direct trial available found no benefit over placebo. If you have diabetes or take medication for it, or are pregnant or nursing, talk to a doctor before adding any supplement.

Related reading: does turmeric help with anxiety?, who should not take turmeric, and how much turmeric should you take a day?.

Sources

  1. The effectiveness and safety of nanocurcumin supplementation for diabetic peripheral neuropathy in patients with type 2 diabetes: a randomized double-blind clinical trial Nutrition journal · 2025 · PMID 40682175The one randomized controlled trial designed specifically to test curcumin for diabetic nerve pain — 97 people with type 2 diabetes, 16 weeks, 80 mg/day nanocurcumin — found no significant improvement in pain, nerve function or disability scores compared with placebo, and no change in metabolic or cardiovascular markers either. It was well tolerated with no major adverse events.
  2. Curcumin Ameliorates the Experimental Diabetic Peripheral Neuropathy through Promotion of NGF Expression in Rats Chemistry & biodiversity · 2022 · PMID 35538560In diabetic rats, curcumin (100-150 mg/kg/day for 4 weeks) improved measures of nerve function and reduced nerve-cell death in the sciatic nerve compared with untreated diabetic rats, without changing blood sugar itself — an animal study showing a plausible mechanism, not a human result.
  3. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial Phytotherapy research : PTR · 2020 · PMID 31788880An 8-week trial of 80 mg/day nano-curcumin in 80 people with diabetes and diagnosed peripheral nerve damage found a significantly greater reduction in anxiety and depression scores versus placebo, but no significant difference in stress scores; the population was diagnosed with a diabetes complication, not a general anxious population.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.